EFFECTIVENESS AND SAFETY OF INTRAVENOUS USTEKINUMAB INTENSIFICATION IN CROHN'S DISEASE WITH LOSS OF RESPONSE OR PARTIAL RESPONSE TO SUBCUTANEOUS THERAPY.

Autor:	Migeon, F., Fouillet, J., Rubira, L., Donzé, C., Eberlé, M. C., Fersing, C.
Zdroj:	European Journal of Hospital Pharmacy; 2024 Supplement, Vol. 31, pA143-A144, 2p
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu